A cost‐effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first‐line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan.

Autor: Su, Po‐Jung, Xiao, Ying, Lin, Amy Y., Goh, Connie, Wu, Ethan, Liu, Kevin, Chou, Patrick, Kuo, Kaitlin, Palencia, Roberto, Chang, Jane, Kearney, Mairead, Kapetanakis, Venediktos, Benedict, Agnes
Zdroj: Cancer Reports; Oct2023, Vol. 6 Issue 10, p1-13, 13p
Databáze: Complementary Index
Externí odkaz: